Long‐term safety and effectiveness of azathioprine in the management of inflammatory bowel disease: A real‐world experience

BACKGROUND AND AIM: Azathioprine (AZA) forms the cornerstone for maintenance of sustained remission in inflammatory bowel disease (IBD). There is apprehension regarding the long‐term effectiveness and safety of AZA in IBD. We present our experience with AZA use and outcomes in a cohort of IBD patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Yewale, Rohan V, Ramakrishna, Balakrishnan S, Doraisamy, Babu Vinish, Basumani, Pandurangan, Venkataraman, Jayanthi, Jayaraman, Kayalvizhi, Murali, Ananthavadivelu, Premkumar, Karunakaran, Kumar, Akkim Sathish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517446/
https://www.ncbi.nlm.nih.gov/pubmed/37744710
http://dx.doi.org/10.1002/jgh3.12955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517446/
https://www.ncbi.nlm.nih.gov/pubmed/37744710
http://dx.doi.org/10.1002/jgh3.12955

Ejemplares similares